Pulmonary outcomes of incretin-based therapies in COPD patients receiving single-inhaler triple therapy

Pulmonary outcomes of incretin-based therapies in COPD patients receiving single-inhaler triple therapy

Background Patients with COPD on triple therapy often face exacerbations and comorbidities. Emerging evidence suggests that glucagon-like peptide-1 (GLP-1) analogues may reduce the risk of exacerbation in patients with COPD and type 2 diabetes mellitus (T2DM). This study investigates the impact of G...

Full description

Saved in:
Bibliographic Details
Main Authors: Xin Ya See, Nutchapon Xanthavanij, Yu-Che Lee, Tze Ern Ong, Tsu Hsien Wang, Omer Ahmed, Yu-Cheng Chang, Chun-Yu Peng, Kuan-Yu Chi, Yu Chang, Ko-Yun Chang, Cho-Han Chiang
Format: Article
Language:English
Published: European Respiratory Society 2025-04-01
Series:ERJ Open Research
Online Access:http://openres.ersjournals.com/content/11/2/00803-2024.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items